EUR 13.06
(1.08%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 134.44 Million EUR | 6.06% |
2022 | 126.76 Million EUR | 17.71% |
2021 | 107.69 Million EUR | -20.85% |
2020 | 136.05 Million EUR | 46.08% |
2019 | 93.13 Million EUR | -1.08% |
2018 | 94.15 Million EUR | 39.76% |
2017 | 67.36 Million EUR | -51.38% |
2016 | 138.56 Million EUR | 21.91% |
2015 | 113.65 Million EUR | 18.27% |
2014 | 96.09 Million EUR | 9.24% |
2013 | 87.96 Million EUR | 1.24% |
2012 | 86.88 Million EUR | -10.62% |
2011 | 97.21 Million EUR | -32.7% |
2010 | 144.46 Million EUR | 28.6% |
2009 | 112.33 Million EUR | 0.0% |
2008 | 112.33 Million EUR | 60.83% |
2007 | 69.84 Million EUR | 30.93% |
2006 | 53.34 Million EUR | 21.64% |
2005 | 43.85 Million EUR | -27.76% |
2004 | 60.7 Million EUR | -12.59% |
2003 | 69.45 Million EUR | -22.16% |
2002 | 89.22 Million EUR | -2.77% |
2001 | 91.76 Million EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 69.83 Million EUR | 0.0% |
2023 FY | 134.44 Million EUR | 6.06% |
2023 Q4 | 89.4 Million EUR | 0.0% |
2023 Q2 | 45.03 Million EUR | 0.0% |
2022 Q4 | 64.18 Million EUR | 0.0% |
2022 Q2 | 62.57 Million EUR | 0.0% |
2022 FY | 126.76 Million EUR | 17.71% |
2021 Q4 | 62.62 Million EUR | 0.0% |
2021 FY | 107.69 Million EUR | -20.85% |
2021 Q2 | 45.07 Million EUR | 0.0% |
2020 Q2 | 34.94 Million EUR | 0.0% |
2020 Q4 | 101.1 Million EUR | 0.0% |
2020 FY | 136.05 Million EUR | 46.08% |
2019 FY | 93.13 Million EUR | -1.08% |
2019 Q2 | 28.97 Million EUR | 0.0% |
2019 Q4 | 64.16 Million EUR | 0.0% |
2018 Q2 | 27.9 Million EUR | 0.0% |
2018 FY | 94.15 Million EUR | 39.76% |
2017 FY | 67.36 Million EUR | -51.38% |
2017 Q2 | 54.95 Million EUR | 0.0% |
2016 Q4 | 74.31 Million EUR | 0.0% |
2016 FY | 138.56 Million EUR | 21.91% |
2016 Q2 | 64.24 Million EUR | 0.0% |
2015 Q2 | 53.34 Million EUR | 0.0% |
2015 Q4 | 60.31 Million EUR | 0.0% |
2015 FY | 113.65 Million EUR | 18.27% |
2014 Q2 | 43.04 Million EUR | 0.0% |
2014 FY | 96.09 Million EUR | 9.24% |
2013 Q4 | 46.85 Million EUR | 0.0% |
2013 FY | 87.96 Million EUR | 1.24% |
2013 Q2 | 41.11 Million EUR | 0.0% |
2012 FY | 86.88 Million EUR | -10.62% |
2012 Q4 | 22.1 Million EUR | 1.77% |
2012 Q3 | 21.72 Million EUR | 0.0% |
2012 Q2 | 21.72 Million EUR | 0.0% |
2012 Q1 | 21.72 Million EUR | 0.0% |
2011 Q2 | 24.3 Million EUR | 0.0% |
2011 Q4 | 21.72 Million EUR | -10.62% |
2011 FY | 97.21 Million EUR | -32.7% |
2011 Q3 | 24.3 Million EUR | 0.0% |
2011 Q1 | 24.3 Million EUR | 0.0% |
2010 Q3 | 36.11 Million EUR | 0.0% |
2010 FY | 144.46 Million EUR | 28.6% |
2010 Q4 | 24.3 Million EUR | -32.7% |
2010 Q1 | 36.11 Million EUR | 0.0% |
2010 Q2 | 36.11 Million EUR | 0.0% |
2009 FY | 112.33 Million EUR | 0.0% |
2009 Q3 | 28.08 Million EUR | 0.0% |
2009 Q2 | 28.08 Million EUR | 0.0% |
2009 Q4 | 36.11 Million EUR | 28.6% |
2009 Q1 | 28.08 Million EUR | 0.0% |
2008 FY | 112.33 Million EUR | 60.83% |
2008 Q4 | 28.08 Million EUR | 0.0% |
2008 Q3 | 28.08 Million EUR | 0.0% |
2008 Q2 | 28.08 Million EUR | 0.0% |
2008 Q1 | 28.08 Million EUR | 0.0% |
2007 Q4 | 28.08 Million EUR | 60.83% |
2007 FY | 69.84 Million EUR | 30.93% |
2007 Q1 | 17.46 Million EUR | 0.0% |
2007 Q2 | 17.46 Million EUR | 0.0% |
2007 Q3 | 17.46 Million EUR | 0.0% |
2006 FY | 53.34 Million EUR | 21.64% |
2006 Q4 | 17.46 Million EUR | 30.93% |
2006 Q2 | 13.33 Million EUR | 0.0% |
2006 Q1 | 13.33 Million EUR | 0.0% |
2006 Q3 | 13.33 Million EUR | 0.0% |
2005 Q2 | 10.96 Million EUR | 0.0% |
2005 Q3 | 10.96 Million EUR | 0.0% |
2005 FY | 43.85 Million EUR | -27.76% |
2005 Q4 | 13.33 Million EUR | 21.64% |
2005 Q1 | 10.96 Million EUR | 0.0% |
2004 Q2 | 15.17 Million EUR | 0.0% |
2004 Q4 | 10.96 Million EUR | -27.76% |
2004 FY | 60.7 Million EUR | -12.59% |
2004 Q1 | 15.17 Million EUR | 0.0% |
2004 Q3 | 15.17 Million EUR | 0.0% |
2003 Q1 | 17.36 Million EUR | 0.0% |
2003 Q4 | 15.17 Million EUR | -12.59% |
2003 Q2 | 17.36 Million EUR | 0.0% |
2003 Q3 | 17.36 Million EUR | 0.0% |
2003 FY | 69.45 Million EUR | -22.16% |
2002 Q4 | 17.36 Million EUR | -22.16% |
2002 Q3 | 22.3 Million EUR | 0.0% |
2002 Q1 | 22.3 Million EUR | 0.0% |
2002 Q2 | 22.3 Million EUR | 0.0% |
2002 FY | 89.22 Million EUR | -2.77% |
2001 FY | 91.76 Million EUR | 0.0% |
2001 Q4 | 22.3 Million EUR | -2.77% |
2001 Q3 | 22.94 Million EUR | 0.0% |
2001 Q1 | 22.94 Million EUR | 0.0% |
2001 Q2 | 22.94 Million EUR | 0.0% |
2000 Q4 | 22.94 Million EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Affluent Medical SA | -1.2 Million EUR | 11303.417% |
Bluelinea Société Anonyme | -3.84 Million EUR | 3594.166% |
Carmat SA | -30.97 Million EUR | 534.087% |
Diagnostic Medical Systems S.A. | 15.84 Million EUR | -748.583% |
Euromedis Groupe | 3.57 Million EUR | -3664.193% |
Eurobio Scientific Société anonyme | 53.96 Million EUR | -149.122% |
Ikonisys S.A. | 255.82 Thousand EUR | -52451.529% |
Implanet S.A. | 3.13 Million EUR | -4192.497% |
Median Technologies SA | -2.55 Million EUR | 5370.129% |
SpineGuard SA | 3.37 Million EUR | -3878.658% |
Theraclion SA | -1.08 Million EUR | 12543.805% |
Euroapi S.A. | 164.6 Million EUR | 18.323% |
Guerbet SA | 197.14 Million EUR | 31.807% |
Koninklijke Philips N.V. | 7.44 Billion EUR | 98.195% |
Sequana Medical NV | 548.04 Thousand EUR | -24430.836% |